Advancing Patient-Centered Innovation and Nonprofit Sustainability Through Strategic Engagement

Advancing Patient-Centered Innovation and Nonprofit Sustainability Through Strategic Engagement

Congredior:
A Latin word meaning "to meet," "to approach," "to engage."
PEO:
An abbreviation for
"Patient Engagement Optimization" & "Philanthropy Engagement Optimization"
CongrediorPEO
is a leading strategic consultancy specializing in patient engagement solutions
and full-service nonprofit fundraising consulting.
Patient Engagement Practice
We partner with pharmaceutical, biotech, clinical research, and patient advocacy organizations to
integrate patient insights across the product lifecycle, from clinical trial design to
post-launch strategies, ensuring patient voices drive meaningful outcomes.
Philanthropy Engagement Practice
Offering comprehensive fundraising services, including grant research and writing, major gift and
corporate solicitations, and annual campaign planning and execution, our evidence-based approach
helps mission-driven organizations build sustainable funding models,
strengthen donor relationships, and achieve measurable impact.
We have expertise across the nonprofit sector, including healthcare, patient organizations,
arts organizations, religious entities, and educational institutions.
With over 70 years of combined expertise and a collaborative network of subject-matter specialists, CongrediorPEO provides agile, data-driven strategies that empower organizations to thrive in complex healthcare, advocacy, and philanthropy landscapes.

In early clinical trial design, it is esssential to gain the perspectives and insights of the patients who will eventually enroll in a clinical trial. We initiate early-stage protocol reviews with patient populations to guide protocol developmet for optimum clinical trial recruitment success.

We excel at creating Patient Advisory Boards populated by patients and thought leaders. Insights from PABs are vital to clinical trial design and all patient-facing materials and media. Whether it is a global, national, or regional PAB, we mange every aspect of
in-person, remote, and hybrid meetings, working closely with clients' marketing/legal/regulatory processes.

From formulary preferences to packaging, patients provide critical insights into how a therapy can best meet the needs of end-users. Focus groups and surveys are important tools to gain critical insights that lead to successful treatment opportunities. We work with patient organizations and other thought leaders to recruit focus group members, as well as develop and disseminate surveys.

The voice of the patient is a powerful tool to help drug makers gain inroads into clinical trial enrollment, as well as pre- and post-launch awareness initiatives. Our expertise in recruiting and training patient ambassadors helps our clients gain critical exposure within their target patient population.

Working closely with our pharmaceutical/biotech clients, we help identify and prepare patient experts and thought leaders to provide input at FDA Patient Listening Sessions and other regulatory agency meetings.

Engaging with patient organizations that represent a particular disease cohort is key to successful engagement initiatives. The team at CongrediorPEO has more than 20 years of nonprofit management and engagement experience. Such experience makes our company the ideal partner to manage the intricacies of PO and pharmaceutical/biotech industry relations.

We proudly work with small and medium sized nonprofit patient organizations. We specialize in developing strategies and programs that prepare organizations to engage in patient-focused drug development partnerships with the pharmaceutical/biotech industry.

CongrediorPEO’s strategic fundraising planning services help organizations build a clear, achievable roadmap for long‑term revenue growth. The team evaluates current fundraising performance, identifies opportunities, and designs multi‑year strategies aligned with mission and capacity. This includes donor pipeline development, goal setting, resource planning, and strengthening internal systems. By creating a focused, data‑informed plan, our clients are more impowered to pursue sustainable fundraising success with confidence and clarity.

Our expertise in prospect research and donor analytics services gives organizations a clearer view of who their strongest supporters are and where new opportunities exist. We analyze donor data, identifie high‑capacity prospects, and uncover giving patterns that inform smarter fundraising strategies. By combining wealth insights, engagement trends, and predictive indicators, our experts equip nonprofits with actionable intelligence that strengthens donor pipelines and boosts long‑term fundraising performance.

We provide comprehensive campaign development and management services across Capital, Annual, and Major Gift campaigns. We begin with feasibility assessments, readiness analysis, and clear goal setting, followed by crafting cases for support, prospect strategies, and detailed campaign plans that align leadership and staff. During implementation, we offer hands‑on project management, donor engagement support, and performance monitoring to maintain momentum, adapt to opportunities, and drive strong fundraising results.

A strong Case for Support and Messaging Development is critical for any philanthropic initiative. We help organizations articulate a clear, compelling narrative that inspires donor confidence. Our services include refining mission language, defining key value propositions, and crafting persuasive campaign materials tailored to target audiences.
We also support message alignment across leadership and staff, ensuring every communication reinforces the organization’s purpose and impact. This work equips nonprofits with a unified, donor‑ready story that drives stronger fundraising results.

Board leadership and capacity‑building services strengthen a nonprofit’s ability to fundraise effectively by developing confident, engaged, and strategically aligned leaders. We provide board training, governance assessments, and coaching to improve roles, responsibilities, and fundraising participation. Our experts also help organizations build internal systems, clarify decision‑making structures, and cultivate a culture of accountability.
Together, these services expand an organization’s long‑term fundraising capacity and overall organizational resilience.
At CongrediorPEO, our values are based on the belief that the patient perspective is more than a data point, it’s direction. It guides our decisions, shapes our partnerships, and fuels our innovation. At the heart of everything we do is a belief in the power of collaboration, integrity, transparency, and patient-centered progress.
We believe that when drug development reflects the full spectrum of human diversity, science becomes more powerful, outcomes become more meaningful, and society becomes healthier.
With a deep commitment to inclusion, we work to ensure that every patient voice is heard, valued, and represented. We actively seek to engage participants from all walks of life, embracing differences in race, ethnicity, gender, age, and socioeconomic background.
We know that reducing barriers to participation is essential to building trust and driving progress. That is why we partner with pharmaceutical and biotech companies, CROs, patient organizations, and advocacy groups to create engagement strategies that are equitable, transparent, and transformative.
By listening deeply and acting boldly, we are dedicated to shaping a future where drug development mirrors the richness of humanity and unlocks innovations that lead to healthier futures.

CongrediorPEO is dedicated to advancing patient-focused drug development through customized, data-driven engagement initiatives. We unite pharmaceutical and biotech companies, clinical research organizations, and patient communities to amplify diverse voices, reduce barriers to participation, and build trust. Through equitable collaborations, we drive healthcare innovation for improved patient outcomes and a healthier society.
CongrediorPEO envisions a future where patient-focused drug development is consistently driven by measurable best practices in engagement strategies. By fostering trust and collaboration among all stakeholders in the drug development process, we strive to amplify diverse voices and transform healthcare innovation to achieve greater therapeutic opportunities and meaningful patient outcomes.
Leading the company's client relations, strategic partners, and subject-matter experts is Managing Director Robert J. Riggs. With three decades of expertise at the intersection of healthcare marketing, patient advocacy, and data-driven engagement programs, Robert has built a distinguished record of elevating patient perspectives from data points to strategic mandates.
He is recognized for designing and leading high-impact initiatives across the nonprofit, pharmaceutical, biotech, and clinical research sectors, guiding organizations through strategic change and forging global advocacy alliances.
Robert’s philanthropic leadership includes multimillion-dollar fundraising campaigns, sustainable development infrastructures, and the cultivation of high-value donor, board, and corporate relationships that accelerate long-term growth.
His fundraising expertise spans grant research and writing, major gift and corporate solicitations, and annual campaign strategy and execution, supported by disciplined operations and high-performing team development.
Grounded in strategic planning and a deep understanding of healthcare and philanthropic ecosystems, Robert integrates community insight with organizational strategy to lead with clarity, empathy, and impact.
Contact Robert at rriggs@congrediorpeo.com
Kate Ryland brings over three decades of experience spanning philanthropy and healthcare to CongrediorPEO. She began her career in private banking as an analyst, advising high-net-worth individuals, families, and family foundations on achieving their philanthropic goals. After 23 successful years as a trusted philanthropic advisor, Kate transitioned to the pharmaceutical industry, where she spent over a decade leading corporate philanthropy initiatives that advanced patient engagement and supported critical health programs.
Over the course of her career, Kate has directed more than $1 billion in philanthropic support to museums, performing arts organizations, hospitals, public and private schools, patient advocacy groups, and research institutions.
Her unique perspective, shaped by years of working with philanthropists and understanding what motivates their giving, enables her to design fundraising strategies that resonate with donors and deliver meaningful impact. Combined with her deep expertise in healthcare engagement, Kate provides our clients with insights and resources that drive results and foster lasting connections.
Contact Kate at kryland@congrediorpeo.com

We know that our clients have unique needs. Send us a message, and we will get back to you as soon as possible.
3104 East Camelback Road, Ste. 1238 | Phoenix, Arizona 85016 | USA
We're proud to launch Congredior Philanthropy Engagement Optimization, formalizing our ongoing fund development services to mission-driven organizations. This expansion reflects our strategic commitment to applying our stakeholder‑engagement expertise to the nonprofit sector.
Founded on our commitment to patient-focused drug development, we continue to work with our pharma and CRO clients through rigorous engagement initiatives while expanding to meet the growing need for sophisticated fundraising capabilities across the philanthropic landscape.
Website & logo updates are underway!
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.